Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism 
Tencent Reviews Marvelous Stake as Gaming Giant Reassesses Global Investment Strategy 
WiseTech Global Denies Knowledge of Investigation Into Founder Richard White 
Nissan Halts Electric Qashqai Development Amid EV Market Challenges 
Trip.com Shares Tumble After Q1 Profit Drops and Weak Revenue Growth Outlook 
Fortescue Faces Class Action Over Sexual Harassment Claims at Australian Mining Sites 
Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence 
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices 
Baseten Secures $1.5 Billion Funding at $13 Billion Valuation Amid AI Infrastructure Boom 
SK Hynix Targets $29.4 Billion Nasdaq Listing to Expand AI Chip Business 
Micron Stock Surges on Strong AI Demand, Record Revenue, and Bullish Q4 Forecast 
Meta Reportedly Developing ‘Arena’ Prediction Market App to Rival Polymarket and Kalshi 
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy 
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom 
FedEx Stock Drops After Weak 2026 Earnings Forecast Despite Strong Q4 Results 
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan 
Doncasters Raises $919 Million in NYSE IPO as Aerospace Growth Accelerates 
CAMBRIDGE, Mass., Feb. 24, 2016 -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its presentation at two upcoming investor conferences.
Cowen & Company 36th Annual Health Care Conference
Monday, March 7, 2016 at 4:00 p.m. ET in Boston, MA
Barclays Global Healthcare Conference
Tuesday, March 15, 2016 at 4:50 p.m. ET in Miami, FL
The audio webcast of the presentation will be available live on the “Investors” section of the company’s website located at www.momentapharma.com. A replay of the presentation will be posted on the Momenta website approximately one hour after the event and will be available for two weeks following the presentation.
About Momenta
Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for oncology and autoimmune indications.
To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.
Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.
Contact: Sarah Carmody Momenta Pharmaceuticals 1-617-395-5189 [email protected]
